Hiscox (LON:HSX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a report released on Monday,Digital Look reports. They currently have a GBX 2,150 price objective on the stock. Berenberg Bank’s price target suggests a potential upside of 18.72% from the company’s previous close.
Other research analysts have also issued reports about the company. JPMorgan Chase & Co. lifted their price objective on Hiscox from GBX 1,800 to GBX 2,050 and gave the stock an “overweight” rating in a research report on Friday, July 10th. Jefferies Financial Group restated an “underperform” rating and set a GBX 1,148 target price on shares of Hiscox in a research report on Thursday, May 7th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 2,000 target price on shares of Hiscox in a research note on Thursday, August 6th. Citigroup lifted their target price on Hiscox from GBX 1,611 to GBX 1,846 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Finally, Peel Hunt reissued an “add” rating and issued a GBX 1,960 price target on shares of Hiscox in a research note on Wednesday, August 5th. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 1,838.14.
Get Our Latest Report on Hiscox
Hiscox Stock Up 0.9%
About Hiscox
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd’s of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
Featured Articles
- Five stocks we like better than Hiscox
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Hiscox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hiscox and related companies with MarketBeat.com's FREE daily email newsletter.
